Analysis of the cannabidiol effects in epilepsy treatment based on seizure characteristics in EEG recordings - A review

Epileptic Disord. 2025 Dec;27(6):1148-1167. doi: 10.1002/epd2.70085. Epub 2025 Sep 11.

Abstract

Epilepsy is a common neurological disorder with a significant burden on patients, and ~30% of cases are resistant to standard antiepileptic treatments. This has led to the exploration of alternative therapies, such as cannabidiol (CBD). Studies suggest that CBD may reduce the frequency and severity of seizures in patients with drug-resistant epilepsy. In addition to clinical monitoring, EEG is frequently used to assess brain function and monitor CBD's effects on seizures, with documented improvements in EEG patterns among CBD-treated patients. Research indicates that CBD may decrease both the number and duration of seizures, observed clinically and in EEG manifestations. This narrative review summarizes current evidence on the efficacy of CBD in treating drug-resistant epilepsy and analyzes its mechanisms of action in various forms of treatment-resistant seizures and their EEG presentations.

Keywords: EEG; brain signals; cannabidiol; epilepsy.

Publication types

  • Review

MeSH terms

  • Anticonvulsants* / pharmacology
  • Anticonvulsants* / therapeutic use
  • Cannabidiol* / pharmacology
  • Cannabidiol* / therapeutic use
  • Drug Resistant Epilepsy* / drug therapy
  • Drug Resistant Epilepsy* / physiopathology
  • Electroencephalography* / drug effects
  • Epilepsy* / drug therapy
  • Epilepsy* / physiopathology
  • Humans
  • Seizures* / drug therapy
  • Seizures* / physiopathology

Substances

  • Cannabidiol
  • Anticonvulsants